Editor's update: Emily Ashkin is featured in a podcast from The Lasker Foundation. My legs were starting to ache from standing by my research poster …
Young scientists contributed to research that revealed the structures of enzymes behind the common disorder G6PD deficiency.
Tracking a pain-relief device's success in patients who aren't in clinical trials is seen as a promising approach to expanding treatment options for kids.
Blood levels of a brain-derived substance in people in their 90s and 100s accurately predict how much longer they're going to live.
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
A Stanford-led study of twins with and without food allergies has uncovered differences in the fecal bacteria of allergic and non-allergic individuals.
Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.
Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.
Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.
Stanford Medicine magazine's most-read articles of 2020 were about COVID-19, grieving and chemo brain, a misunderstood side effect of chemotherapy.
The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.
Stanford researchers have created a molecular probe designed to map how the brain works by tagging, recording and controlling functions of individual cells.
Stanford Health Care physician Megan Mahoney, MD, describes how conversations with family helped her decide to be among the first to get the COVID-19 vaccine.
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.